What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Malaria
- Disease
The scientist’s investigation covers issues in Malaria, Immunology, Plasmodium falciparum, Virology and Malaria vaccine.
His Malaria study combines topics from a wide range of disciplines, such as Demography, Incidence and Pediatrics.
His research related to Vaccination, Circumsporozoite protein, T cell, Antigen and Immune system might be considered part of Immunology.
His Virology research incorporates elements of Antibody, Clinical trial and Anopheles.
Philip Bejon works in the field of Malaria vaccine, focusing on RTS,S in particular.
His biological study spans a wide range of topics, including Internal medicine and Rabies.
His most cited work include:
- First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. (684 citations)
- A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. (550 citations)
- Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age (350 citations)
What are the main themes of his work throughout his whole career to date?
Philip Bejon mainly investigates Malaria, Immunology, Plasmodium falciparum, Virology and Malaria vaccine.
His Malaria study combines topics in areas such as Internal medicine, Epidemiology, Demography and Pediatrics.
His work on Gametocyte as part of general Plasmodium falciparum study is frequently connected to Parasite hosting, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His Virology research is multidisciplinary, relying on both T cell, ELISPOT, Cellular immunity, Circumsporozoite protein and Immunogenicity.
His work on RTS,S as part of general Malaria vaccine research is frequently linked to Rabies vaccine, thereby connecting diverse disciplines of science.
His Vaccination study incorporates themes from Adverse effect and Immunization.
He most often published in these fields:
- Malaria (98.01%)
- Immunology (55.68%)
- Plasmodium falciparum (52.56%)
What were the highlights of his more recent work (between 2018-2021)?
- Malaria (98.01%)
- Demography (21.59%)
- Plasmodium falciparum (52.56%)
In recent papers he was focusing on the following fields of study:
Philip Bejon focuses on Malaria, Demography, Plasmodium falciparum, Internal medicine and Public health.
Malaria is a subfield of Immunology that he tackles.
His Demography research includes elements of Incidence, Vitamin D and neurology, vitamin D deficiency, Meta-analysis and Seroprevalence.
His Plasmodium falciparum research includes themes of Transmission and Immunity.
His research integrates issues of Yellow fever vaccine, Yellow fever and Seroconversion in his study of Internal medicine.
The Seroconversion study which covers Vaccination that intersects with Adverse effect.
Between 2018 and 2021, his most popular works were:
- Oral versus intravenous antibiotics for bone and joint infection (196 citations)
- Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors (59 citations)
- Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors (59 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Malaria
- Disease
Philip Bejon mainly focuses on Malaria, Seroprevalence, Severe acute respiratory syndrome coronavirus 2, Plasmodium falciparum and Internal medicine.
His Malaria research is classified as research in Immunology.
His studies deal with areas such as Kenya and Environmental health as well as Seroprevalence.
His research in Plasmodium falciparum intersects with topics in Latent class model and Rapid diagnostic test.
His Internal medicine research integrates issues from Orthopedic surgery and Intravenous antibiotics.
His study explores the link between Drug resistance and topics such as Lumefantrine that cross with problems in Virology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
